News Tag: Corporate Information

At the same time, it’s important to emphasize that we are still in an early stage. Growth is occurring from relatively low levels, but the pace is exceptional. During the first quarter of 2025, we activated as many units delivering medication daily as we had over the entire first five years since the original version of Dosell was developed – a significant milestone.

Our business model now shows clear scalability, with more active Dosell units generating a growing stream of recurring revenue. We are entering a commercial breakthrough phase with record-high momentum, fueled by demand from both municipalities and international partners.

Sweden: More municipalities onboard – focus on long-term expansion
In March, three new municipalities began using Dosell. We also signed a direct procurement agreement with a municipality that, after completing a pilot, decided to fully transition to Dosell from a previously used solution. They highlight its simplicity, reliability, and the fact that doses are not locked if missed – giving both users greater independence and care services increased flexibility in scheduling.

Another municipality has launched a pilot under our structured “municipal package,” and we have several ongoing tenders within home care and LSS (disability services). Every week, we receive new inquiries – a clear signal of a shifting market where scalable, modern solutions are increasingly in demand.

At the same time, it is important to point out that volumes per municipality are still relatively low. Our focus moving forward is to support each municipality in identifying more users, increasing usage, and maximizing societal benefit. As the population ages, care must scale – and with digital tools like Dosell, we can ensure safe and high-quality care for more people without overburdening resources.

The Netherlands: Strong customer onboarding and launch of Dosell TV
In the Netherlands, we continue to meet our growth forecast. Our partner TCCN reports that their largest customer, MobileCare, delivered an additional 72 units in March. Interest is growing steadily, with more organizations joining the system each week.

In April, TCCN is launching the first broadcast of Dosell TV – a new platform to share knowledge, inspire, and support new organizations in getting started. It is a concrete step towards scaling implementation and building a vibrant user and partner community. In parallel, TCCN is also exhibiting Dosell at a major trade fair in the Netherlands in April – a key opportunity to reach new customers and further strengthen our market position.

Spain: Pharmacy network and strong role in Savioo Home
The launch of Dosell in Spain through the Savioo Home concept is now underway. Our partner has attended several trade fairs in Barcelona and France, where Dosell was presented as a central component for ensuring proper medication adherence at home.

Over 50 pharmacies have already expressed interest in adopting the concept and will soon receive promotional materials for in-store and window displays. This is only the beginning – these 50 pharmacies are the first wave in a network of 1,500 that our partner is actively working with. The ambition is high, and we see a serious, long-term effort that lays the foundation for success.

Expansion: Engaging new markets and new partners
We are currently in active discussions with new potential partners, both in existing and new geographies. Interest is coming from both public and private sectors, all recognizing the need for digital medication management. Our strategy remains clear: grow with the right partners – those with the drive and ability to scale.

To Our Shareholders – Why We Believe in Our Direction
iZafe Group is stronger than ever. We have a highly demanded solution, a growing customer network, and a proven business model. At the same time, we remain humble about the fact that we are still in a building phase – but something has clearly shifted.

We’ve set a new pace in the market, delivering more active units in one quarter than in our first five years combined – and this is just the beginning. With the momentum we’re experiencing, combined with our long-term strategy, our belief is stronger than ever: Dosell has the potential to become a cornerstone in the future of medication management.

Thank you for following our journey – and for your continued trust.

Spain: Official Launch and Initial Market Activities
After an intensive preparation phase, we have now officially launched Dosell in Spain! Spain has one of the largest healthcare markets in Europe, with over 22,000 pharmacies and an aging population driving demand for digital medication management solutions. This presents significant growth potential and an opportunity to establish Dosell as a leading solution in the market.
Our partner Ti-Medi has initiated marketing efforts by introducing the Savioo platform to all of its 1,500 pharmacies via email and through direct visits to pharmacies in multiple cities, including Barcelona, Girona, Lleida, Granollers, and Madrid. They currently produce dose sachets for 200,000 users, highlighting the significant potential for Dosell in the Spanish market.
To further strengthen our presence, we plan to gain media exposure in the near future, which will open new doors and increase awareness of Dosell in Spain. At the same time, Ti-Medi will be showcasing the Savioo concept along with Dosell at a major trade fair in Barcelona this March, providing additional visibility and opportunities to reach more industry players.

Sweden: Four New Municipalities in Operation and More on the Way
We launched Dosell in four new municipalities in February, while also conducting training sessions for two additional municipalities that plan to implement Dosell in March. Additionally, six new municipalities have expressed interest in adopting Dosell, with four of them already scheduling startup meetings in March and planning to activate their first units in April.
This represents a faster growth rate in terms of the number of municipalities than initially planned. Despite the positive development, we recognize that some challenges remain, particularly regarding the speed of implementation and initial volumes. While we have successfully introduced Dosell in multiple new municipalities in Sweden, the initial deployment is still relatively small-scale. To enhance scalability, we are focusing on improving training efforts for healthcare staff and simplifying the ordering process. However, municipalities plan to increase the number of units over time, reinforcing our strategy and our partners’ efforts to scale up Dosell’s implementation across Sweden.
Some of the feedback we have received from users and staff:

• User: “I don’t have to think anymore! Finally, I get my medication at the right time, and when it lights up and beeps, I know it's time to take it.”
• Healthcare Staff: “If a user hasn’t taken their medication, a simple phone call is enough to follow up—we don’t have to make a home visit.”
• Healthcare Staff: “We chose Dosell as our medication dispenser because it is so simple and fits perfectly with all our municipality’s needs.”

The Netherlands: Stable Growth and Expanding Pipeline
Our market in the Netherlands continues to develop positively, with steadily increasing demand. Our partner's pipeline of new customers is growing, and we anticipate a high activation rate of Dosell units throughout the spring. Their investment in Dosell continues to yield results and is creating a stable platform for future expansion.
Additionally, our partner will be showcasing Dosell at a major trade fair in the Netherlands in April, which we believe will drive an even greater increase in sales.
We recommend following our partner’s journey in the Netherlands through their LinkedIn page, TCCN, for the latest updates and market developments.

Expansion and New Partnerships
Throughout February, we engaged in several exciting discussions with potential new partners in emerging markets. Moving forward, our strategy is to select partners with the best conditions for scaling Dosell on a larger scale. It is crucial to collaborate with organizations that understand how to implement digital technology and manage the necessary transformation processes required for successfully adopting Dosell.

We look forward to continued positive development in March and to building on the strong foundation we have established for our growth. We appreciate your engagement and look forward to sharing more progress in the upcoming updates!

The acquisition is a clear signal of Magnus long-term confidence in iZafe's strategy and future potential. His total holding now amounts to 200,000 B-shares.

"I see great potential in iZafe's continued development and want to demonstrate my commitment by investing in the company. We have a clear growth strategy, and I am convinced that we are creating long-term value for our shareholders," says Magnus Engman.

Dosell has already established itself as an effective solution in countries such as Sweden and the Netherlands, helping users take the right medication at the right time. Through the partnership with Ti-Medi, Dosell will now be available to the Spanish market, integrating with Ti-Medi’s existing network of over 1,500 pharmacies that utilize their packaging technology for pre-dosed medications.
With Dosell, patients using Savioo Home will receive reminders to take their medication, and if they fail to do so on time, an automatic SMS alert will be sent to relatives or caregivers. This feature ensures a higher level of safety and security for both patients and their loved ones.

A Strategic Partnership for the Future
"We see tremendous potential in the Spanish market and are proud to launch Dosell through our collaboration with Ti-Medi. This is an important step in our international growth journey and our ambition to become a global leader in medication adherence," says Anders Segerström, CEO of iZafe Group.

"At Ti-Medi, we strive to provide technological solutions that simplify patients’ lives and optimize the work of healthcare professionals. Savioo Home not only automates medication management at home but also enhances security for patients, relatives, and pharmacists. This enables more precise monitoring and better adherence to treatment. We believe that the future of healthcare lies in digitalization and tools that increase safety, convenience, and trust – and Savioo Home is a major step in that direction," Says Rafa Tibau, Pharmacist and Co-founder of Ti-Medi

About Ti-Medi
Ti-Medi is a pioneer in pharmaceutical technology in Southern Europe, serving more than 1,500 pharmacies with advanced packaging and dosing solutions. The company’s mission is to enhance medication adherence and make healthcare more accessible and efficient. Read more at ti-medi.com

For more information about Savioo Home and how it can improve medication adherence and patient safety, visit the website savioo.com

If you are not yet receiving these updates via email, be sure to subscribe at the bottom of our website or through the link in our latest LinkedIn post. Follow us on LinkedIn for continuous updates.

Continuous Growth and Key Milestones
The number of billable Dosell units increased by 25% from December to January, a clear sign that our strategy and partnerships are driving demand.

Our growth is still from a smaller scale, but it is steadily increasing, bringing us closer to a key milestone of 1,000 active Dosell units in use. We expect to reach this soon, marking a significant step in our expansion.

Our business model is based on partners purchasing and stocking Dosell, ensuring cost coverage at the time of sale. The long-term value is generated when the units are activated, creating a recurring monthly revenue stream.

We have already shipped 2,500 Dosell units to our partners, who are experiencing strong demand and expect to activate them within 3–6 months. This increasing activation rate drives our revenue stream, creating a stable and scalable business model.

Sweden: Strong Momentum in VGR and More Municipalities Adopting Dosell
Dosell usage in Västra Götaland Region (VGR) has increased by 18% since December, and interest from municipalities continues to grow. We now have seven new municipalities scheduled for implementation in Q1, both within and outside VGR.

Our partners are actively driving Dosell through existing framework agreements, which accelerates deployment. To meet rising demand and support municipalities with implementation, we will host a webinar for VGR municipalities on March 6 in collaboration with ATEA.

At the MVTe trade fair, Dosell continued to generate strong interest from municipalities and private healthcare providers. Several follow-up meetings are scheduled in February.

Here are just a few comments from Swedish municipal staff, caregivers, and users about Dosell:

"We placed a Dosell with a user who was very skeptical at first. But after just a few days, she was thrilled that she could manage her medication independently while knowing that home care had full control in case she forgot."

"Our municipal staff was highly impressed after seeing Dosell presented. Compared to the larger, more complicated devices we previously used, Dosell will greatly simplify daily work."

"It is so easy to learn!"

"Using Dosell was the best decision we made. My father feels secure, and I receive alerts if anything deviates."

"When many other things started to become difficult due to memory loss, medication management continued to function thanks to Dosell."

Norway: Faster Implementation Through Partnerships
In Norway, we have partnered with Randstad to accelerate implementations and ensure optimal Dosell usage throughout contract periods.
In January, we conducted a comprehensive training session with Hepro, Careium AS, and Randstad to ensure a smooth rollout and equip their sales teams with the right tools for driving adoption.

Netherlands: Stable and Long-Term Growth
The Netherlands continues to be a key market with steady growth in Dosell adoption. Our partner has successfully integrated Dosell into its own platform, "Dispenze", which has been highly appreciated by customers. More organizations are now replacing competing solutions with Dosell.

A testament to our partner’s long-term commitment is their investment in a Dosell showroom, office, and branded delivery vehicles.

Follow TCCN on LinkedIn for regular insights and updates on how Dosell is used in the Netherlands.

Spain: Launch Around the Corner
Ti-medi has developed a comprehensive system and e-commerce solution to ensure a successful Dosell launch in Spain. The process has taken longer than expected, but we anticipate the launch happening in February.

Product Development: Improvements Drive Demand
Over the past year, we have released 13 software versions, and we are soon launching version 14, which includes significant enhancements.

Our goal has always been clear: Dosell should be simple and reliable for users, while we continuously improve refill processes, integrations, and the overall experience for caregivers and partners.

These ongoing improvements have been key to the growth we see today. Dosell is now more efficient than ever, which in turn drives increased demand.

Capital Raise and Focus on Profitability
We would also like to take this opportunity to thank our major shareholders for their support in the directed share issue of approximately SEK 9.2 million.

This capital injection strengthens our ability to accelerate growth while maintaining a clear focus on cost efficiency and achieving cash flow profitability.

We look forward to sharing more details in our upcoming quarterly report next week – stay tuned!

Our partners have purchased hardware with the expectation of implementing these units within a relatively short period, which strengthens our business model of generating recurring monthly revenue.

The launch of Dosell 3.0 marks a milestone with improved functionality and integration. At the same time, we have changed production partners and built efficient production workflows, making us ready to scale up production to meet increasing demand and ensure high quality in every delivery. This work has laid a solid foundation for continued success.

Our innovative efforts have led to several new integrations, such as with Enovation UMO, and strong collaborations with partners like TCCN in the Netherlands and Ti Medi in Spain. These advancements reinforce Dosell as a global leader in health technology, providing solutions that enhance safety and independence for both users and healthcare staff. In Sweden, we have successfully implemented Dosell in numerous municipalities. Our solutions have been appreciated for their user-friendliness, safety, and ability to prevent medication errors. This has not only improved user independence but also streamlined the work of healthcare professionals. This success underscores Dosell's central role in digitalizing and optimizing healthcare at the municipal level.

Looking Ahead to 2025 With a solid foundation in place, we look forward to accelerating our growth. Our pipeline is strong, and we expect 2025 to build on the successes of this year. We plan to further expand Dosell’s presence while giving Pilloxa a central role in our portfolio. These initiatives will enable more innovative solutions and strengthen our position as a leader in health technology. We aim to continue creating value for our customers and shareholders through sustainable and profitable growth.

Thank You for Your Support I would like to extend my heartfelt thanks to our employees, partners, and shareholders. It is through your dedication and commitment that we can continue building a brighter future for healthcare and for iZafe Group. We look forward to 2025 with great ambition and strong confidence in our shared potential.

With warmth and appreciation,
Anders Segerström CEO, iZafe Group

A Long-Awaited Solution for Dutch Partners
The certification has been highly anticipated by iZafe's partners in the Netherlands, where Enovation UMO is a well-established standard in healthcare. These partners have been eager to begin selling Dosell and can now leverage the seamless integration with the UMO platform. This ensures that Dosell not only complements but also enhances their offering by providing a comprehensive solution for medication management, alarms, and other digital healthcare services within the same platform.

"Creating a Unique Market Position"
"This certification is a critical milestone for iZafe and our partners, especially in the Dutch market, where interest in Dosell is substantial," says Anders Segerström, CEO of iZafe Group AB. "Dosell is specifically designed to be part of a healthcare technology ecosystem, and integrations like this not only simplify implementation but also improve the experience for both users and caregivers."

Benefits of an Integrated Ecosystem
By becoming certified on Enovation UMO, Dosell establishes a unique market position. Offering an integrated solution that handles medication management, alarms, and other care needs within a single platform meets the growing demand for comprehensive solutions in digital healthcare. This not only enhances iZafe's appeal to healthcare providers but also enables its partners to deliver a more competitive and value-driven offering to their customers.

Opening Doors to More Markets
Beyond the Netherlands, this integration also creates opportunities for iZafe to expand into other markets where Enovation UMO is established. With the platform’s presence in 18 countries, iZafe has a unique opportunity to strengthen its international presence and build relationships with new partners and customers.

A Step Forward for iZafe’s Growth Strategy
The certification is part of iZafe’s broader strategy to establish Dosell as a key component of the global healthcare technology landscape. By collaborating with established platforms like Enovation UMO, iZafe demonstrates its commitment to innovation and its ability to meet market demands for integrated and efficient healthcare solutions.
 
About Enovation Platform
Enovation UMO is part of the Enovation Platform: the leading platform for digital care and collaboration. With over 350 partners worldwide, the platform offers a wide variety of integrations. Enovation Platform uses open software, which connects seamlessly to care organisations' systems and those of their partner organisations. This way, the platform provides all the digital tools care professionals need to support patients or clients – whatever their needs.
https://enovationgroup.com/en/enovation-umo/